MF
LPCN icon

Manchester Financial’s Lipocine LPCN Stock Holding History

Manchester Financial’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29
Closed -$1K – 624
2020
Q3 		$1K Hold
29
– – ﹤0.01% 523
2020
Q2 		$1K Hold
29
– – ﹤0.01% 490
2020
Q1 		$0 Hold
29
– – ﹤0.01% 552
2019
Q4 		$0 Buy
+29
New +$743 ﹤0.01% 565
2019
Q3 		– Sell
-29
Closed -$1K – 269
2019
Q2 		$1K Buy
+29
New +$895 ﹤0.01% 471

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Manchester Financial's LPCN Position: Q4 2020 in Review

Manchester Financial sold out of Lipocine (LPCN) in Q4 2020, closing a stake of 29 shares — an estimated $1K sold.

Manchester Financial first reported a position in LPCN in Q2 2019 and held it in 5 quarters. The position peaked at $1K in Q3 2020. 33 funds tracked by Wall St. Rank hold LPCN as of Q4 2020.

  • Manchester Financial reported no remaining Lipocine position as of Q4 2020 after selling out during the quarter.
  • Manchester Financial sold 29 Lipocine shares in Q4 2020, an estimated $1K.
  • Manchester Financial first reported a position in Lipocine in Q2 2019 and held it in 5 quarters.
  • Manchester Financial's Lipocine position peaked at $1K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Lipocine as of Q4 2020.

Based on Manchester Financial's 13F filing for Q4 2020, filed 26 Jan 2021.